Funding Opportunity RFA-DA-22-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including amphetamine, methamphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.

Funding Opportunity RFA-AG-22-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits secondary analyses of existing datasets to provide evidence about appropriate strategies for long-term osteoporosis therapies, including drug holidays, and to better understand their risks and benefits.

Notice NOT-AI-21-064 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-084 from the NIH Guide for Grants and Contracts

Notice NOT-AA-21-033 from the NIH Guide for Grants and Contracts

Spurred by the pandemic and a colleague’s sudden death, these scientists are making contingency plans

Applicants should have strong scientific communication skills and scientific integrity. We also seek candidates from broad areas (e.g., biophysics, biochemistry…
From Medical College of Wisconsin - Thu, 17 Jun 2021 03:18:33 GMT - View all Milwaukee, WI jobs

£50000 - £70000 per annum: CK Group: CK Group are looking for a Senior/Principal Statistician to join a specialist CRO, with a special focus on unmet needs in such areas as Oncology,... London

Up to £13 per hour PAYE: CK Group: CK Group are recruiting for a Stability Analyst to join a company in the Pharmaceutical industry at their site based in Blackpool on a contract... Blackpool

£15.48 ph (PAYE) / £20.79 ph Umb: CK Group: CK Group are recruiting for a Stability Analyst to join a company in the Pharmaceutical industry at their site based in Blackpool on a contract... Blackpool

A strong background in biochemistry, molecular biology, high-throughput sequencing or coding/bioinformatics will be advantageous.
From University of Wisconsin–Madison - Wed, 16 Jun 2021 18:57:10 GMT - View all Madison, WI jobs

Excellent knowledge in cancer biology, algorithm development and data analysis. Apply best practice statistical/computational methods to analyze large-scale…
From Illumina - Wed, 16 Jun 2021 18:10:26 GMT - View all Madison, WI jobs

Notice NOT-AG-21-026 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-025 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-22-017 from the NIH Guide for Grants and Contracts. NIDA is interested in research that addresses research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the effects of substance use on PrEP effectiveness and better inform PrEP implementation among substance users. More systematic data are needed regarding the impact of substance use on PrEP management and adherence, along with investigating potential unintended consequences of PrEP use that may be unique to substance users. This RFA is restricted to projects conducted in the United States, although foreign components are permitted where they support domestic research in the United States. Applications are encouraged that propose research in states and counties identified in the US Governments Ending the HIV Epidemic (EtHE) initiative as described here: Ending the HIV Epidemic: A Plan for America https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview. Applications to work in locales that are not included in the EtHE initiative must provide an epidemiologic justification for their inclusion in the research.

Funding Opportunity RFA-AG-22-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) aims to explore the role of adaptive immunity in Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). Specifically, the FOA seeks an understanding of brain immune surveillance, the generation of CNS-directed immune responses in neurodegenerative disorders, and the functional role of adaptive immunity in AD/ADRD onset and progression.

n/a: SRG: Sequencing Scientist Location: London Contract: Permanent Pay Rate: Competitive Salary + Excellent Benefits London, England

Notice NOT-GM-21-060 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-21-264 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) issued by AHRQ invites grant applications for funding to conduct Large Health Services Research Demonstration and Dissemination Projects (R18) that propose to address strategies and approaches for prevention and reduction of Healthcare-Associated Infections (HAIs). This FOA describes the broad areas of HAI research for which funds are available to support Health Services Research Demonstration and Dissemination Projects.

Funding Opportunity RFA-AI-20-069 from the NIH Guide for Grants and Contracts. The purpose of this FOA is encourage and support the development of effective strategies for expanding the provision of HIV pre-exposure prophylaxis (PrEP) in sexually transmitted infection (STI) service settings in high priority jurisdictions identified by the presidential initiative, Ending the HIV Epidemic: A Plan for America. Funding for the fourth and fifth years (s) will be dependent upon achieving negotiated go/no go criteria and milestones.